Global Human Microbiome Sequencing Services Market Growth (Status and Outlook) 2024-2030

Global Human Microbiome Sequencing Services Market Growth (Status and Outlook) 2024-2030

Human Microbiome Sequencing Services refer to specialized services provided by companies or research institutions that analyze the genetic material of microbial communities found in the human body. These services involve extracting, sequencing, and interpreting the DNA and RNA of microbes, including bacteria, viruses, fungi, and other microorganisms, to understand their composition, functions, and interactions within the human host.

Human Microbiome Sequencing Services are pivotal in advancing our understanding of the complex relationships between the human host and its resident microbes, contributing significantly to medical research, healthcare, and beyond.

The global Human Microbiome Sequencing Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Human Microbiome Sequencing Services Industry Forecast” looks at past sales and reviews total world Human Microbiome Sequencing Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Microbiome Sequencing Services sales for 2023 through 2029. With Human Microbiome Sequencing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Microbiome Sequencing Services industry.

This Insight Report provides a comprehensive analysis of the global Human Microbiome Sequencing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Microbiome Sequencing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Microbiome Sequencing Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Microbiome Sequencing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Microbiome Sequencing Services.

United States market for Human Microbiome Sequencing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Human Microbiome Sequencing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Human Microbiome Sequencing Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Human Microbiome Sequencing Services players cover Illumina, IGATech, Genetic Analysis, BaseClear, Microba Life Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Microbiome Sequencing Services market by product type, application, key players and key regions and countries.

Segmentation by Type:

16S rRNA Sequencing

Shot Gun Metagenomics

Metatranscriptomics

Others

Segmentation by Application:

Hospitals

Research Institutes

Pharmaceutical Companies

This report also splits the market by region:

Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:

16S rRNA Sequencing

Shot Gun Metagenomics

Metatranscriptomics

Others

Segmentation by Application:

Hospitals

Research Institutes

Pharmaceutical Companies

This report also splits the market by region:

Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Illumina

IGATech

Genetic Analysis

BaseClear

Microba Life Sciences

Viome

Goodgut

Origin Sciences

Ixcela

ProDigest

Enterome

The BioCollective

ZOE

Qiagen

Please note: The report will take approximately 2 business days to prepare and deliver.